Biologics Standards for Innovation, Quality and Access

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 06 Oct, 21:11 UTC

This GEN Spotlight on Biologics Standards for Innovation, Quality and Access brings together experts from across biopharma, standards development, and analytical science to examine the challenges of testing increasingly complex modalities, including monoclonal antibodies, cell and gene therapies…

science

Sources

• T2Biologics Standards for Innovation, Quality and AccessFierce Biotech / Fierce Healthcare / MedCity / GEN06 Oct, 21:11